Cited by 11Diabetes, Cardiovascular Risks, and LipoproteinsIndigenous Health and EducationAdipokines, Inflammation, and Metabolic Diseases

Comparative Analysis of Metabolic Syndrome Diagnostic Criteria and Its Effects on Prevalence in a Multiethnic Population

Open access
Asato, Chloe B.H., Nelson-Hurwitz, Denise C., Lee, Thomas, Grandinetti, Andrew·2021·Metabolic Syndrome and Related Disorders

Abstract

Background: Accurate prevalence measurement and diagnosis to prevent type 2 diabetes mellitus and cardiovascular disease cannot occur without consistent diagnostic criteria that can be applied to varying populations. Objective: The objective of this study was to determine the prevalence of metabolic syndrome in Caucasian, Filipino, Native Hawaiian, and Japanese populations utilizing different definitions. Methods: This study utilized cross-sectional study data from the Native Hawaiian/Multiethnic Health Research Project, collected from a population living in Kohala, Hawai‘i. The National Cholesterol Education Program–Adult Treatment Panel III (NCEP-ATPII), International Diabetes Federation (IDF), and World Health Organization (WHO) definitions were utilized, and each of the 1452 participants were evaluated on the criteria for metabolic syndrome based on all three definitions. Additionally, the average biomarker values associated with the diagnosis were taken for each ethnic group represented in the study and compared with Caucasians. Results: The overall prevalence of metabolic syndrome in this population varied from 22.31% to 39.05% using the different definitions. Ethnic disparities also occur, implying that certain populations are more prone to having severe abnormalities than others—shown when comparing the average biomarker values associated with metabolic syndrome diagnosis. Of all ethnic groups included in the study, Caucasians had the lowest prevalence of metabolic syndrome, while part-Hawaiians had the highest prevalence. Additionally, within the same ethnic group, the definitions yielded varying prevalence values. Conclusions: This implies that discrepancies exist among the criteria alone. Implications of this study revolve around not only the correct definition to apply to the population being studied but also the most accurate way to detect certain biomarker abnormalities to accurately assess the prevalence of metabolic syndrome in a multiethnic population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/met.2020.0090

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The discrepancy in external validation underscores the potential influence of region- and population-specific factors on model transferability.

    “This discrepancy underscores the potential influence of region- and population-specific factors on model transferability, such as differences in dietary patterns, genetic susceptibility, and variations in metabolic phenotypes [38–41].”

    From Machine learning with the body roundness index and associated indicators: a new approach to predicting metabolic syndrome (2025) · cites this paper as [39]

    The Discussion (page unavailable) says that differences between the China and Kohala findings may reflect the populations studied, and the Results report that diagnostic criteria performed differently by ethnicity. This supports the general relevance of population-specific factors, but the paper does not assess external validation or predictive-model transferability, or establish dietary patterns or genetic susceptibility as explanations. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. [6]6. Grundy SM, Becker D, Clark LT, et al. Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Circulation 2002;106:3143-3421.
  2. [11]11. Alberti KGMM, Aschner P, Assal JP, et al. Definition, diagnosis, and classification of diabetes mellitus and its complications. Diabet Med 1998;15:1-59.

Cited by

Sorted by citations

Authors
Asato, C. B. H., Nelson-Hurwitz, D. C., Lee, T., & Grandinetti, A.
Affiliations
University of Hawaiʻi at Mānoa (US)
Corresponding author
Asato, Chloe B.H.
Venue
Metabolic Syndrome and Related Disorders
Published
2021-08-01
Volume
19
Issue
6
Pages
347-351
ISSN
  • 1540-4196 (ISSN-L)
  • 1557-8518
OpenAlex
W3134211635
Cited by
11
References
14
Citations by year
2026: 1 · 2025: 4 · 2023: 1 · 2022: 4 · 2019: 1
FWCI
0.93
Type
journal article
Language
en
Open access
Locations
  • Metabolic Syndrome and Related Disorders (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Center for Research Resources (G12RR003061)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Health Professions › General Health Professions › Indigenous Health and Education
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
metabolic syndrome, diagnostic criteria, NCEP ATP III criteria, IDF criteria, WHO criteria, prevalence, ethnic disparities, multi-ethnic population, Native Hawaiians, Filipinos, Japanese Americans, Caucasians, biomarkers, type 2 diabetes prevention, cardiovascular risk
MeSH terms
Adult, Cross-Sectional Studies, Ethnicity, Humans, Prevalence, Cultural Diversity, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review